Upregulation of NOR-1 in calcified human vascular tissues

Cardiovascular calcification is a significant public health issue whose pathophysiology is not fully understood. NOR-1 regulates critical processes in cardiovascular remodeling, but its contribution to ectopic calcification is unknown. NOR-1 was overexpressed in human calcific aortic valves and calc...

Full description

Bibliographic Details
Authors: Ballester-Servera, Carme|||0000-0001-7858-3064, Cañes Esteve, Laia|||0000-0002-9579-1321, Alonso Nieto, Judith|||0000-0003-0537-0417, Puertas Umbert, Lídia|||0000-0002-2739-6522, Vázquez-Sufuentes, Paula|||0009-0001-3369-9087, Tauron, Manel|||0000-0002-5864-519X, Roselló-Díez, Elena|||0000-0003-2258-3246, Marín, Francisco|||0000-0001-7246-7708, Rodríguez, Cristina|||0000-0002-6472-5647, Martínez-González, José|||0000-0002-3894-7166
Format: article
Publication Date:2024
Country:España
Institution:Universitat Autònoma de Barcelona
Repository:Dipòsit Digital de Documents de la UAB
Language:English
OAI Identifier:oai:ddd.uab.cat:298701
Online Access:https://ddd.uab.cat/record/298701
https://dx.doi.org/urn:doi:10.1016/j.trsl.2023.09.004
Access Level:Open access
Keyword:Atherosclerosis
Cardiovascular calcification
NOR-1
Osteogenic differentiation
Description
Summary:Cardiovascular calcification is a significant public health issue whose pathophysiology is not fully understood. NOR-1 regulates critical processes in cardiovascular remodeling, but its contribution to ectopic calcification is unknown. NOR-1 was overexpressed in human calcific aortic valves and calcified atherosclerotic lesions colocalizing with RUNX2, a factor essential for osteochondrogenic differentiation and calcification. NOR-1 and osteogenic markers were upregulated in calcifying human valvular interstitial cells (VICs) and human vascular smooth muscle cells (VSMCs). Gain- and loss-of-function approaches demonstrated that NOR-1 negatively modulates the expression of osteogenic genes relevant for the osteogenic transdifferentiation (RUNX2, IL-6, BMP2, and ALPL) and calcification of VICs. VSMCs from transgenic mice overexpressing NOR-1 in these cells (TgNOR-1) expressed lower basal levels of osteogenic genes (IL-6, BMP2, ALPL, OPN) than cells from WT littermates, and their upregulation by a high-phosphate osteogenic medium (OM) was completely prevented by NOR-1 transgenesis. Consistently, this was associated with a dramatic reduction in the calcification of both transgenic VSMCs and aortic rings from TgNOR-1 mice exposed to OM. Atherosclerosis and calcification were induce in mice by the administration of AAV-PCSK9 and a high-fat/high-cholesterol diet. Challenged-TgNOR-1 mice exhibited decreased vascular expression of osteogenic markers, and both less atherosclerotic burden (assessed in whole aorta and lesion size in aortic arch and brachiocephalic artery) and less vascular calcification (assessed either by near-infrared fluorescence imaging or histological analysis) than WT mice. Our data indicate that NOR-1 negatively modulates the expression of genes critically involved in the osteogenic differentiation of VICs and VSMCs, thereby restraining ectopic cardiovascular calcification.